Prevalence and Risk Factors of Metabolic Dysfunction-associated Steatotic Liver Disease

被引：0
|
作者：
Plaza-Aulestia, Nahia [1 ]
Ibarguengoitia-Barrena, Oihane [2 ]
Sampedro-Andrada, Blanca [3 ]
Juan-Lopez, Cristina San [3 ]
Morillo-Montanes, Victoria [4 ]
Urionaguena, Irati [5 ]
Calvo, Itziar [6 ]
Seisdedos, David Montero [7 ]
Vega-Alvarez, Lucia [2 ]
Llorente, Jose Francisco Garcia [2 ]
Revenga, Nuria Vegas [8 ]
机构：
[1] Galdakao Usansolo Univ Hosp, Div Rheumatol, Galdakao, Spain
[2] Galdakao Usansolo Univ Hosp, Div Rheumatol, Bilbao, Spain
[3] Galdakao Usansolo Univ Hosp, Digest Div, Galdakao, Spain
[4] Galdakao Usansolo Univ Hosp, Div Dermatol, Galdakao, Spain
[5] Galdakao Usansolo Univ Hosp, Div Rheumatol, Gernika Lumo, Spain
[6] Hosp Univ Basurto, Bilbao, Spain
[7] Galdakao Usansolo Univ Hosp, Bilbao, Spain
[8] Hosp Galdakao Usansolo, Galdakao, Spain
来源：
ARTHRITIS & RHEUMATOLOGY | 2024年 / 76卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
2321
引用
收藏
页码：4669 / 4671
页数：3
相关论文
共 50 条
  • [21] Insulin resistance and cardiovascular risk factors in childhood metabolic dysfunction-associated steatotic liver disease
    Gumus, Meltem
    Yorulmaz, Alaaddin
    Candan, Hakan
    Ergani, Anna Carina
    Kaya, Reyhan
    Bugrul, Fuat
    Vatansev, Huesamettin
    Emiroglu, Halil Haldun
    CUKUROVA MEDICAL JOURNAL, 2023, 48 (03): : 1115 - 1130
  • [22] Clinical and genetic risk factors for progressive fibrosis in metabolic dysfunction-associated steatotic liver disease
    Kaplan, David E.
    Teerlink, Craig C.
    Schwantes-An, Tae-Hwi
    Norden-Krichmar, Trina M.
    DuVall, Scott L.
    Morgan, Timothy R.
    Tsao, Philip S.
    Voight, Benjamin F.
    Lynch, Julie A.
    Vujkovic, Marijana
    Chang, Kyong-Mi
    HEPATOLOGY COMMUNICATIONS, 2024, 8 (07)
  • [23] Nutrients associated with metabolic dysfunction-associated steatotic liver disease
    Jeong, Seogsong
    JOURNAL OF HEPATOLOGY, 2024, 80 (02) : e81 - e82
  • [24] From metabolic dysfunction-associated fatty liver disease to metabolic dysfunction-associated steatotic liver disease: Controversy and consensus
    Chen, Li
    WORLD JOURNAL OF HEPATOLOGY, 2023, 15 (12) : 1253 - 1257
  • [25] Socioeconomic factors associated with the presence of and outcomes in metabolic dysfunction-associated steatotic liver disease
    Nasr, Patrik
    Shang, Ying
    Wester, Axel
    Strandberg, Rickard
    Widman, Linnea
    Lazarus, Jeffrey V.
    Hagstrom, Hannes
    LIVER INTERNATIONAL, 2024, 44 (11) : 3050 - 3059
  • [26] Management of cardiovascular risk in patients with metabolic dysfunction-associated steatotic liver disease
    Mellemkjaer, Anders
    Kjaer, Mikkel Breinholt
    Haldrup, David
    Gronbaek, Henning
    Thomsen, Karen Louise
    EUROPEAN JOURNAL OF INTERNAL MEDICINE, 2024, 122 : 28 - 34
  • [27] Metabolic Dysfunction-Associated Steatotic Liver Disease: Pathogenetic Links to Cardiovascular Risk
    Ionescu, Vlad Alexandru
    Gheorghe, Gina
    Bacalbasa, Nicolae
    Diaconu, Camelia Cristina
    BIOMOLECULES, 2025, 15 (02)
  • [28] Metabolic dysfunction-associated steatotic liver disease and cardiovascular risk: a comprehensive review
    Zheng, Haixiang
    Sechi, Leonardo Antonio
    Navarese, Eliano Pio
    Casu, Gavino
    Vidili, Gianpaolo
    CARDIOVASCULAR DIABETOLOGY, 2024, 23 (01)
  • [29] Metabolic dysfunction-associated steatotic liver disease and cancer risk: A cohort study
    Peng, Yu
    Wang, Peng
    Liu, Fubin
    Wang, Xixuan
    Si, Changyu
    Gong, Jianxiao
    Zhou, Huijun
    Gu, Jiale
    Qin, Ailing
    Song, Weijie
    Song, Fangfang
    DIABETES OBESITY & METABOLISM, 2025, 27 (04): : 1940 - 1949
  • [30] Increased risk of cancers in metabolic dysfunction-associated steatotic liver disease and MetALD
    Park, Yewan
    Jung, Jooyi
    Kim, Gi-Ae
    JOURNAL OF HEPATOLOGY, 2024, 80 : S468 - S468
12345